超越表面:P2Y受体下游通路,TLR交叉声和对感染和自身免疫的治疗影响
Lena Rueschpler1, Sebastian Schloer1
1Institute for Immunology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg 20251, Germany.
Pharmacological research
|July 31, 2025
概括
纯能系统平衡免疫防御和组织损伤,影响自身免疫性疾病. 准P2Y受体为炎症状况提供了治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 免疫反应需要精确调节促进和抗炎信号,以清除病原体和组织平衡.
- 纯能系统,涉及P2Y受体,在免疫中发挥双重作用,促进抗菌作用,同时限制炎症.
- 纯能系统的失调与自身免疫性疾病有关.
研究的目的:
- 为提供P2Y受体下游信号的全面概述.
- 阐明P2Y受体,托尔类受体 (TLRs) 和炎症酶激活之间的交叉声.
- 评估针对炎症性疾病中的P2Y受体的治疗潜力.
主要方法:
- 对P2Y受体最近的临床前和临床研究的综述.
- 对P2Y受体下游信号通路的分析.
- 检查P2Y受体,TLR和炎症酶之间的相互作用.
主要成果:
- P2Y受体在免疫反应中表现出双重作用,影响效应机制和分辨率.
- P2Y受体,TLRs和炎症体之间的交叉声是不完全理解的,但对于免疫调节至关重要.
- 偏差信号和新的药理学策略是针对P2Y受体向治疗的重要考虑因素.
结论:
- P2Y受体是免疫平衡和炎症的关键调节者.
- 准P2Y受体对各种炎症和自身免疫性疾病具有显著的治疗前景.
- 对P2Y受体信号及其相互作用的进一步研究对于开发有效的治疗方法至关重要.
相关概念视频
Interactions Between Signaling Pathways
6.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.5K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Inflammatory Response
7.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
7.5K
Amplifying Signals via Second Messengers
7.3K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
7.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
646
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
646


